Invesco Preferred ETF vs Tilray Brands Inc — how do they compare? Invesco Preferred ETF trades at $10.04 (market cap $3.64B), while Tilray Brands Inc trades at $3.64 (market cap $549.01M). The key difference: Invesco Preferred ETF is far larger — about 6.6× Tilray Brands Inc's market cap, and Invesco Preferred ETF is more actively traded (6,969,114 versus 3,292,073). Which is the better fit depends on your goals — on Pluang, investors hold Invesco Preferred ETF for 94 Days and Tilray Brands Inc for 31 Days on average.
| PGX | TLRY | |
|---|---|---|
Market Cap | $3.64B | $549.01M |
Volume | 6,969,114 | 3,292,073 |
52-Week High | $11.61 | $21.00 |
52-Week Low | $9.97 | $3.57 |
Typical Hold Time | 94 Days | 31 Days |
Sector | — | Health |
Enterprise Value | — | $716.15M |
Signals from Pluang's Aura AI — not financial advice
PGX trades at $9.97, down 0.89% with a bearish technical signal from moving averages despite oversold RSI readings. The stock shows identical support and resistance at $10, indicating consolidation. Recent dividend payments of $0.06 were declared for July and September 2026, providing income appeal. Financial ratios including P/E, P/S, and ROE are unavailable in current data, limiting fundamental visibility.
The outlook remains cautious due to bearish technical momentum and lack of current financial metrics. Income investors may find dividend payments attractive, but absence of earnings data and weak price action suggest near-term pressure. Key risks include undefined profitability and competitive challenges in the preferred ETF space highlighted by recent media coverage.
Tilray Brands (TLRY) trades at $3.715, down 1.72% on the day, as the stock continues to face significant pressure with bearish technical signals and fundamental challenges. The company reported a substantial net loss of $2.19 billion in 2025 despite $821 million in revenue, with negative cash flow from operations of $94.6 million. Recent earnings have consistently missed expectations, and technical indicators show a bearish trend with the stock trading near key support levels.
While TLRY shows attractive valuation metrics with P/S of 0.45 and P/B of 0.34, the company faces substantial execution risks amid persistent losses and negative cash flow. Analyst sentiment remains cautious with only 25% buy ratings, though the consensus price target of $65.01 suggests significant upside potential if the company can achieve profitability and growth targets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →